| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/16/2004 | EP1427383A1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 06/16/2004 | EP1427377A2 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1339719B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 06/16/2004 | EP1315731B1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/16/2004 | EP1294413B1 Sprayable wound care compositions |
| 06/16/2004 | EP1257556B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1244643B1 Tryptase inhibitors |
| 06/16/2004 | EP1235777B1 Vitamin d analogues |
| 06/16/2004 | EP1233772A4 Boron compounds and complexes as anti-inflammatory agents |
| 06/16/2004 | EP1194411B1 Benzoylpyridazines |
| 06/16/2004 | EP1171140B1 Treatment of hypersensitivity reaction disorders |
| 06/16/2004 | EP1144425B1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 06/16/2004 | EP1109810B1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity |
| 06/16/2004 | EP0788308B1 Polymeric wound healing accelerators |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505601A Novel atisane compound and use thereof |
| 06/16/2004 | CN1505498A Composition for hair and/or scalp |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504573A Confluent protein capable of self-cracking into polypeptide with antibiosis and reparation function |
| 06/16/2004 | CN1504230A Burn healing ointment |
| 06/16/2004 | CN1504226A Traditional Chinese herbal medicine pilatory |
| 06/16/2004 | CN1504217A External use liquid formulation for dermatosis |
| 06/16/2004 | CN1504210A Prepared Chinese traditional medicine for alopecia |
| 06/16/2004 | CN1504207A Medication for curing alopecia |
| 06/16/2004 | CN1504205A Medicine for skin disease |
| 06/16/2004 | CN1504199A Luminescent bio-element and preparation process |
| 06/16/2004 | CN1153574C Use of bacterial cell wall extracts for treating, preventing or removing protozoan or parasite diseases |
| 06/16/2004 | CN1153571C External therapeutic composition for dermatitis |
| 06/15/2004 | US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750234 Regression of skin tumors, skin homeostases and remodeling, epidermal barrier development, hair growth, and especially wound healing. |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750229 Administering to a mammal a pigmentation-changing effective amount of a bowman-birk inhibitor or of natural extract containing a bowman-birk inhibitor |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750205 Motilide compounds |
| 06/15/2004 | US6750202 Inhibitors of procollagen c-proteinase (pcp), for treating fibrosis of the liver |
| 06/15/2004 | US6750198 Treating disorders characterized by a reduction in pigmentation comprising administering an effective amount of the protein dcoh |
| 06/15/2004 | US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749840 Contacting the melanocyte with a melanin synthesis inhibiting amount of a fatty acid synthase (fas) inhibitor (such as cerulenin) to reduce melanin synthesis in the melanocyte |
| 06/15/2004 | US6749839 Photoprotective cosmetic compositions containing aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile and novel aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile |
| 06/15/2004 | CA2311379C Skin rash prevention composition |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/13/2004 | CA2451267A1 Pharmaceutical uses for alpha2delta ligands |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048498A1 Antioxidant, skin preparation for external use, cosmetic and food |
| 06/10/2004 | WO2004048401A1 Peptides and medicinal compositions containing the same |
| 06/10/2004 | WO2004048391A1 Silicon compounds to be used as ligands for retinoid receptors |
| 06/10/2004 | WO2004048366A1 2-oxoindoline derivatives |
| 06/10/2004 | WO2004048356A1 Inorganic ionic molecular crystal |
| 06/10/2004 | WO2004048287A1 Hardening bone compensate and remedy for skin defect using calcium phosphate sustainedly releasing zinc |
| 06/10/2004 | WO2004047850A1 Papaya puree and the use of the same |
| 06/10/2004 | WO2004047846A1 Oil/glycyrrhizin-containing surfactant phase type gel composition |
| 06/10/2004 | WO2004047824A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/10/2004 | WO2004047776A1 Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof |
| 06/10/2004 | WO2004047747A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | WO2004032914A3 Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders |
| 06/10/2004 | WO2004030671A3 Use of 4-amino-quinazolines as anti cancer agents |
| 06/10/2004 | WO2004022569A9 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003048116A3 Esters and amides as ppar-alpha agonists ____________ |
| 06/10/2004 | WO2003032946A3 Ph-sensitive liposomes for targeted drug delivery |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110846 Perylenequinones for use with immunotherapy agents |
| 06/10/2004 | US20040110833 administering a patient an ester of an alpha-ketoalkanoic acid selected from alpha-ketopropionic acid (pyruvate), alpha-keto-butyrate, alpha-ketopentanoate, alpha-keto-3-methyl-pentanoate etc. to treat cytokine mediated inflammatory conditions |
| 06/10/2004 | US20040110831 Urokinase inhibitors |
| 06/10/2004 | US20040110814 amino acid such as glutamic acid, L-arginine, L-cysteine, L-methionine, L-histidine, L-tryptophan, L-tyrosine. |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110794 Novel piperidine derivatives as modulators of chemokine receptors |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110755 for cytokine-mediated diseases such as Crohn's disease; mixture of an immunosuppressant, NSAIDs, angiogenesis inhibitors, steroids, retinoids, or cellular adhesion molecule inhibitor and specific urea- and morpholine-containing compounds |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110752 2-amino-5-((hetero)aryl)-thiazole derivatives; treatment of disorders such as cancer, immunologic disorders and allergic disorders, optionally in combination with other drugs such as immunosuppressants |
| 06/10/2004 | US20040110736 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | US20040109880 Cosmetic and/or pharmaceutical preparations |
| 06/10/2004 | US20040109872 Porifera-based therapeutic compositions for treating and preventing skin diseases |